The Minimal Residual Disease Using Liquid Biopsies in Hematological MalignanciesRafael Colmenares, Rosa Ayala, Noemí Álvarez et al.|Cancers|2022Cited by 41
Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemiaMaría Luz Morales, María Linares, Roberto García-Vicente et al.|Leukemia|2023Cited by 20
Minimal Residual Disease Using Liquid Biopsies in Hematological MalignanciesRafael Colmenares, Rosa Ayala, Noemí Álvarez et al.|Preprints.org|2022Cited by 13
CRISPR/Cas9 Multi-Editing Enhances CAR NK Cells Therapeutic Potential Against Multiple MyelomaEva Castellano, Antonio Valeri, Almudena García-Ortiz et al.|Blood|2024Cited by 5
Clonal hematopoiesis-defining mutations have no impact on the development of thrombosis in a cohort of patients with myeloid pathologyNoemí Álvarez, Rosa Ayala, Alba Rodríguez-García et al.|Leukemia Research|2021Cited by 2